Chi-ho K. Lee

Pokfulam Road
Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Associations of Cardiovascular-Kidney-Metabolic Syndrome With All-Cause and Cardiovascular Death and the Progression of Cardiovascular-Kidney-Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades.

Associations of Cardiovascular-Kidney-Metabolic Syndrome With All-Cause and Cardiovascular Death and the Progression of Cardiovascular-Kidney-Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades.

Journal: Journal of the American Heart Association

Published: August 20, 2026

Pre-donation screening for blood safety: comparison between 3- and 6-month deferral of men who have sex with men and the incorporation of individual risk assessment.

Pre-donation screening for blood safety: comparison between 3- and 6-month deferral of men who have sex with men and the incorporation of individual risk assessment.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: June 18, 2026

Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

Journal: Journal of lipid research

Published: April 15, 2026

Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

Journal: Journal of lipid research

Published: April 15, 2026

Insights from secular trend of major osteoporotic fractures in people with and without diabetes: 15-year population-based study (2009 - 2023).

Insights from secular trend of major osteoporotic fractures in people with and without diabetes: 15-year population-based study (2009 - 2023).

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: April 06, 2026

Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older.

Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older.

Journal: Diabetes, obesity & metabolism

Published: April 02, 2026

Authors' Reply: Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational Gaps.

Authors' Reply: Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational Gaps.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 21, 2026

Impact of herpes zoster and post-zoster SGLT2 inhibitors initiation on cardiorenal outcomes in type 2 diabetes mellitus.

Impact of herpes zoster and post-zoster SGLT2 inhibitors initiation on cardiorenal outcomes in type 2 diabetes mellitus.

Journal: BMC endocrine disorders

Published: December 31, 2025

Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD).

Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD).

Journal: International journal of obesity (2005)

Published: December 03, 2025

Editorial: An Important Step Towards Mastering Metabolic Dysfunction-Associated Steatohepatitis-Targeted Therapy in Diabetes.

Editorial: An Important Step Towards Mastering Metabolic Dysfunction-Associated Steatohepatitis-Targeted Therapy in Diabetes.

Journal: Alimentary pharmacology & therapeutics

Published: September 26, 2025

A Five-Plasma Protein-Based Algorithm for Predicting Incident CKD in Type 2 Diabetes.

A Five-Plasma Protein-Based Algorithm for Predicting Incident CKD in Type 2 Diabetes.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 23, 2025

Benefits of glucagon-like peptide-1 receptor agonists versus pioglitazone for cardio-hepatic outcomes: a territory-wide target trial emulation.

Benefits of glucagon-like peptide-1 receptor agonists versus pioglitazone for cardio-hepatic outcomes: a territory-wide target trial emulation.

Journal: Cardiovascular diabetology

Published: June 11, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026